tiprankstipranks
Advertisement
Advertisement

VRTX Stock Latest News

Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts
Weekend UpdatesAclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts
4d ago
NB
ACRS
Arcturus Therapeutics price target raised to $41 from $20 at Roth Capital
PremiumThe Fly
Arcturus Therapeutics price target raised to $41 from $20 at Roth Capital
7d ago
ARCT
VRTX
Vertex Pharmaceuticals resumed with an Overweight at Morgan Stanley
PremiumThe Fly
Vertex Pharmaceuticals resumed with an Overweight at Morgan Stanley
8d ago
VRTX
Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals
PremiumThe Fly
Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals
8d ago
CRNX
VRTX
Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs
PremiumThe Fly
Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs
8d ago
VRTX
Argenx price target raised to $1,250 from $1,230 at Morgan Stanley
PremiumThe FlyArgenx price target raised to $1,250 from $1,230 at Morgan Stanley
9d ago
ARGX
VRTX
Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors
Premium
Company Announcements
Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors
12d ago
VRTX
Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial
Premium
Company Announcements
Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial
20d ago
VRTX
Private Markets: $1B for Base Power, $545M for Whatnot
PremiumThe Fly
Private Markets: $1B for Base Power, $545M for Whatnot
20d ago
U
GD
Private Markets: Databricks secures $5B as Kalshi targets $40B valuation
PremiumThe Fly
Private Markets: Databricks secures $5B as Kalshi targets $40B valuation
24d ago
AI
IBM
Vertex: Competitive Threat Eases, Pipeline Strength Supports Unchanged $600 Price Target and Buy Rating
PremiumRatings
Vertex: Competitive Threat Eases, Pipeline Strength Supports Unchanged $600 Price Target and Buy Rating
29d ago
VRTX
Vertex Pharmaceuticals added to ‘US 1 List’ at BofA
PremiumThe Fly
Vertex Pharmaceuticals added to ‘US 1 List’ at BofA
29d ago
VRTX
Sionna Therapeutics downgraded to Neutral at Guggenheim after trial miss
PremiumThe FlySionna Therapeutics downgraded to Neutral at Guggenheim after trial miss
1M ago
SION
VRTX
Vertex Pharmaceuticals price target raised to $672 from $605 at BofA
Premium
The Fly
Vertex Pharmaceuticals price target raised to $672 from $605 at BofA
1M ago
SION
VRTX
Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial
Premium
Market News
Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial
1M ago
SION
VRTX
Early notable gainers among liquid option names on August 10th
PremiumThe Fly
Early notable gainers among liquid option names on August 10th
1M ago
APA
AKAM
Vertex Pharmaceuticals price target raised to $565 from $560 at Truist
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $565 from $560 at Truist
1M ago
VRTX
Vertex Pharmaceuticals price target raised to $617 from $615 at Barclays
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $617 from $615 at Barclays
1M ago
VRTX
Vertex Pharmaceuticals Ups 2026 Outlook Amid Heavy Investment
PremiumCompany Announcements
Vertex Pharmaceuticals Ups 2026 Outlook Amid Heavy Investment
1M ago
VRTX
Vertex: Strong Q2 Beat and Raised Revenue Outlook Underpin Buy Rating and Broadening Growth Beyond CF
PremiumRatingsVertex: Strong Q2 Beat and Raised Revenue Outlook Underpin Buy Rating and Broadening Growth Beyond CF
1M ago
VRTX
Vertex: Buy Rating Reaffirmed with Unchanged $585 Price Target on Strong CF Performance and Late-Stage Pipeline Upside
Premium
Ratings
Vertex: Buy Rating Reaffirmed with Unchanged $585 Price Target on Strong CF Performance and Late-Stage Pipeline Upside
1M ago
VRTX
Vertex: Solid CF Fundamentals and Early Pipeline Credit Drive Price Target Raise to $442, Hold Rating Maintained
Premium
Ratings
Vertex: Solid CF Fundamentals and Early Pipeline Credit Drive Price Target Raise to $442, Hold Rating Maintained
1M ago
VRTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >